Hi everyone! I'm Marc Machaalani, IMG from 🇱🇧 and postdoctoral research fellow focusing on kidney cancer at @DanaFarber@harvardmed.
Thrilled to be applying to #InternalMedicine for the #Match2026!
AAMC ID: 15833270
Dr Francesca Jackson-Spence, PhD candidate at @BartsECMC presents final survival data and a novel ctDNA analysis from the @QMBCI led phase II CALYPSO trial at ASCO #GU25 looking at targeting MET in advanced papillary renal cancer @drfrankiejs
Thank you! @lab_rezvani Honored to share our work on engineered NK cells and the promise of cord blood therapies at #ASTCT. Grateful to be part of such an innovative and collaborative field! #NKCells#CellTherapy@MDAndersonNews
An amazing night at the #NobelPrize banquet celebrating with Dr. Ruvkun & Dr. Ambros! A huge achievement in the world of mRNA.
#RNA#RNAtheraphy#mRNA#HiRM
Although ~17%-20% of the U.S. population resides in rural areas, only 3% of medical oncologists practice in rural communities, according to the National Cancer Institute (@theNCI). In fact, the odds of surviving a cancer diagnosis are lower in rural areas, with people being more likely to receive a diagnosis at a later stage and less likely to receive treatment compared to those in cities.
Our ongoing work with the American Cancer Society (@AmericanCancer) is focused on changing that, and we’re grateful to advocates like @PatrickDempsey for helping share stories of those impacted by cancer in rural areas. Together, we’re working to address cancer disparities and improve health outcomes for underserved communities in the U.S. #CloseTheCareGap and #ChangeTheOdds
Learn more: https://t.co/SJN8LzxGbC
This week we got together for the first meeting of our new #Cancer Screening, Prevention and Epidemiology Unit co-led by the wonderful @Jo_WallerPhD
and @ProfManchanda
Lots of post-it notes, chats and laughs - the seeds of new collaborations! 🌱
@QMUL_WIPH
Thrilled to receive NIH funding for this collaborative effort with Ray Schinazi and Haian Fu on the discovery of MPOX virus-targeting antivirals! Grateful to the reviewers for appreciating the team's efforts and preliminary data.
Two fresh publications in @NEJM sequencing rare post CART lymphomas, the first finding CART genetic elements introduced in tumor cells, the second showing independent oncogenic processes. N=1 so no causal inference possible.
https://t.co/OI1CJ1Zhyl…
https://t.co/OI1CJ1Zhyl…